[怀孕期间戒烟]
V Peyronnet1, A-L Le Faou2, I Berlin3
1Service de gynécologue-obstétrique, hôpital Louis-Mourier, AP-HP, Colombes, France.
Revue des maladies respiratoires
|August 29, 2024
概括
怀孕期间吸烟会对母亲和婴儿的健康产生负面影响. 医疗保健提供者应通过咨询,药物治疗和戒断症状管理来支持戒断,以获得更好的结果.
科学领域:
- 产科和妇科 产科和妇科
- 公共卫生 公共卫生
- 成 药物 药物 药物 药物
背景情况:
- 怀孕期间吸烟与不良妊娠和围产期结果有关.
- 独特的生理和社会因素影响孕妇的吸烟行为.
- 怀孕是开始戒烟干预的关键机会.
研究的目的:
- 突出怀孕妇女戒烟的挑战,包括增加尼古丁清除和戒断症状.
- 强调医疗保健专业人员在查烟草使用和成水平方面的作用.
- 概述在怀孕期间戒烟的多学科管理策略.
主要方法:
- 关于孕妇戒烟的当前文献的综述.
- 对法国怀孕期间吸烟患病率的流行病学数据的分析 (2021年).
- 讨论非药理和药理干预措施,包括尼古丁替代疗法.
- 考虑二手烟暴露 (SHS) 和产后复发管理.
主要成果:
- 在2021年,法国有12%的孕妇报告在第三个三个月内吸烟.
- 在怀孕期间戒烟的女性中,产后复发影响了22.4%.
- 在孕妇吸烟者中,电子烟的使用量正在增加,在2021年怀孕前使用的比例为5.4%,在第三季度使用的比例为1.3%.
结论:
- 对于孕妇吸烟者来说,全面的多学科支持至关重要,应对生理变化和心理社会因素.
- 查,戒烟支持,SHS减少和产后复发预防是护理的重要组成部分.
- 需要进一步的研究来评估电子烟在孕妇戒烟方面的有效性和安全性.
更多相关视频
相关概念视频
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
246
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
246
Stress Prevention and Stress Management Techniques IV
28
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
28
CNS Depressants: Alcohol and Nicotine
182
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
182
Stimulants
172
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
172
Drugs Acting on Autonomic Ganglia: Stimulants
1.3K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.3K
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K


